Sun Pharmaceutical Industries

quarterly
yearly
ParticularsSep '22Dec '22Mar '23Jun '23Sep '23
Revenue11,03811,41511,30412,14512,486
Expenses8,6258,9438,8939,3419,695
EBITDA3,0423,1783,1753,5363,473
EBIT2,4322,5182,3322,5622,840
Profit Before Tax2,4122,4712,2402,4812,791
Net Profit2,2602,1882,0172,0132,401
Financial Ratios
Operating Profit Margin28.14%28.63%28.01%27.27%28.93%
Net Profit Margin20.93%19.51%19.94%19.38%19.79%
Earning Per Share (Diluted)9.409.008.308.409.90
Dividends Per Share0.007.500.000.000.00
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ